Psyence Net Income From Continuing Ops from 2010 to 2026
| PBM Stock | USD 2.54 0.08 3.05% |
Net Income From Continuing Ops | First Reported 2010-12-31 | Previous Quarter 910.6 K | Current Value 956.1 K | Quarterly Volatility 12.1 M |
Check Psyence Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Psyence Biomedical's main balance sheet or income statement drivers, such as Net Interest Income of 104.5 K, Interest Income of 115.7 K or Depreciation And Amortization of 3.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.33. Psyence financial statements analysis is a perfect complement when working with Psyence Biomedical Valuation or Volatility modules.
Psyence | Net Income From Continuing Ops | Build AI portfolio with Psyence Stock |
Evaluating Psyence Biomedical's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Psyence Biomedical Ltd's fundamental strength.
Latest Psyence Biomedical's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Psyence Biomedical Ltd over the last few years. It is Psyence Biomedical's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Psyence Biomedical's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Psyence Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (4,340,337) | |
| Geometric Mean | 2,074,940 | |
| Coefficient Of Variation | (279.31) | |
| Mean Deviation | 5,508,084 | |
| Median | (1,858,235) | |
| Standard Deviation | 12,123,010 | |
| Sample Variance | 147T | |
| Range | 52.2M | |
| R-Value | (0.20) | |
| Mean Square Error | 150.7T | |
| R-Squared | 0.04 | |
| Significance | 0.45 | |
| Slope | (472,499) | |
| Total Sum of Squares | 2351.5T |
Psyence Net Income From Continuing Ops History
About Psyence Biomedical Financial Statements
Psyence Biomedical investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Psyence Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 910.6 K | 956.1 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Psyence Biomedical Correlation against competitors. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Will Biotechnology sector continue expanding? Could Psyence diversify its offerings? Factors like these will boost the valuation of Psyence Biomedical. Anticipated expansion of Psyence directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Psyence Biomedical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Psyence Biomedical's market price often diverges from its book value, the accounting figure shown on Psyence's balance sheet. Smart investors calculate Psyence Biomedical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Psyence Biomedical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Psyence Biomedical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Psyence Biomedical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.